Larkspur Health Acquisiti... (LSPR)
NASDAQ: LSPR
· Real-Time Price · USD
22.50
12.83 (132.68%)
At close: Dec 13, 2022, 6:00 AM
Larkspur Health Acquisition Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -16.29B | -121.8B | -112.85B | -110.58B | -107.75B | -92.11M | -1.7M | -1K | -2.17M | -1.53M | -1.04M | -235.07K | -2.07K | -1.9K |
Interest Income | 109.57K | 219.13K | 109.57K | 109.57K | -433 | -110K | -4.89K | -433 | 109.57K | 109.57K | 4.45K | n/a | n/a | n/a |
Pretax Income | -16.82B | -120.72B | -111.47B | -109.07B | -106.25B | -86.35M | -4.69M | -820.82K | -1.99M | -1.35M | -961.07K | -241.07K | -2.07K | -1.9K |
Net Income | -16.81B | -120.72B | -111.47B | -109.07B | -106.25B | -84.86M | -2.98M | -75K | -1.74M | -1.06M | -881.07K | -246.07K | -2.07K | -1.9K |
Selling & General & Admin | 13.38B | 22.69B | 15.36B | 13.53B | 11.21B | 11.88M | 4.91M | 2.18M | 1.53M | 1.53M | 1.04M | 235.27K | 2.07K | 1.9K |
Research & Development | 2.98B | 5.93B | 4.16B | 3.72B | 3.21B | 3.73M | 1.46M | 400K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -81.81M | 93.17B | 93.33B | 93.33B | 93.33B | 80.54M | -632K | -632K | -632K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.36B | 121.87B | 112.84B | 110.58B | 107.75B | 96.16M | 5.74M | 1.95M | 901K | 1.53M | 1.04M | 235.27K | 2.07K | 1.9K |
Interest Expense | 521.26M | 401.36M | 131.39M | -246K | -457K | -110K | -4.89K | -433 | 115K | 115K | 9.89K | 5.43K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.12B | 116.78B | 107.75B | 107.75B | 107.75B | 96.16M | 5.74M | 1.95M | 901K | 1.53M | 1.04M | 235.27K | 2.07K | 1.9K |
Income Tax Expense | -7.29M | -7.84M | -550K | 497K | n/a | 597.55K | 387.55K | -744.95K | -242.51K | -290.06K | -80.06K | 5.43K | n/a | n/a |
Shares Outstanding (Basic) | 31.07M | 11.1M | 988.38K | 623.6M | 975.03M | 8.09M | 8.09M | 8.09M | 8.09M | 10.03M | 10.01M | 10.01M | 10.01M | 2.09M |
Shares Outstanding (Diluted) | 31.07M | 11.1M | 988.38K | 623.6M | 975.03M | 8.09M | 8.09M | 8.09M | 8.09M | 10.03M | 10.01M | 10.01M | 10.01M | 2.09M |
EPS (Basic) | -5.76 | -103.59 | -115.67 | -113.68 | -108.97 | -10.49 | -0.36 | 0.01 | -0.19 | -0.11 | -0.09 | -0.03 | -0.00 | -0.00 |
EPS (Diluted) | -5.76 | -103.59 | -115.67 | -113.68 | -108.97 | -10.49 | -0.36 | 0.01 | -0.19 | -0.11 | -0.09 | -0.03 | -0.00 | -0.00 |
EBITDA | -16.31B | -120.33B | -111.35B | -109.08B | -106.25B | -90.4M | 519.89K | -196.11K | -955K | -955.17K | -957.07K | -241.07K | -2.07K | -1.9K |
EBIT | -816K | -816K | -90.92M | -90.92M | -90.1M | -90.1M | 526.61K | -189.39K | -1.24M | -1.24M | -949K | -233K | n/a | n/a |
Depreciation & Amortization | 132.05K | 427.77K | 417.81K | 459.39K | 163.39K | -105.25K | -17.11K | 26.8K | 317.37K | 344.29K | 189.87K | 104.37K | 109.81K | 55.81K |